# Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents

> **NCT00598715** · PHASE4 · COMPLETED · sponsor: **Deutsches Herzzentrum Muenchen** · enrollment: 450 (actual)

## Conditions studied

- Coronary Artery Disease

## Interventions

- **DEVICE:** Sirolimus eluting stent
- **DEVICE:** Paclitaxel-eluting stent

## Key facts

- **NCT ID:** NCT00598715
- **Lead sponsor:** Deutsches Herzzentrum Muenchen
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-10
- **Primary completion:** 2009-08
- **Final completion:** 2009-08
- **Target enrollment:** 450 (ACTUAL)
- **Last updated:** 2010-12-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00598715

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00598715, "Efficacy Study of Two Different Strategies for Restenosis in Sirolimus-Eluting Stents". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00598715. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*